Ella T. Ward‐Shaw

Ella T. Ward‐Shaw

Auto-generated profile, based on publicly available information

Ella T. Ward‐Shaw

McArdle Laboratory for Cancer Research, Department of Oncology University of Wisconsin‐Madison Madison Wisconsin USA

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 March 2023 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
WWWei Wang
Wei Wang
Megan SpurgeonMegan Spurgeon
Megan Spurgeon
APAli Pope
Ali Pope
SMStephanie McGregor
Stephanie McGregor
EWElla Ward-Shaw
Ella Ward-Shaw
PLPaul Lambert
Paul Lambert
A murine papillomavirus, MmuPV1, infects both cutaneous and mucosal epithelia of laboratory mice and can be used to model high-risk human papillomavirus (HPV) infection and HPV-associated disease. We have shown that estrogen exacerbates papillomavirus-induced cervical disease in HPV-transgenic mice. We have also previously identified stress keratin 17 (K17) as a host factor that supports MmuPV1-induced cutaneous disease. Here, we sought to test the role of estrogen and K17 in MmuPV1 infection and associated disease in the female reproductive tract. We experimentally infected wild-type and K17 knockout (K17KO) mice with MmuPV1 in the female reproductive tract in the presence or absence of exogenous estrogen for 6 mon. We observed that a significantly higher percentage of K17KO mice cleared the virus as opposed to wild-type mice. In estrogen-treated wild-type mice, the MmuPV1 viral copy number was significantly higher compared to untreated mice by as early as 2 wk postinfection, suggesting that estrogen may help facilitate MmuPV1 infection and/or establishment. Consistent with this, viral clearance was not observed in either wild-type or K17KO mice when treated with estrogen. Furthermore, neoplastic disease progression and cervical carcinogenesis were supported by the presence of K17 and exacerbated by estrogen treatment. Subsequent analyses indicated that estrogen treatment induces a systemic immunosuppressive state in MmuPV1-infected animals and that both estrogen and K17 modulate the local intratumoral immune microenvironment within MmuPV1-induced neoplastic lesions. Collectively, these findings suggest that estrogen and K17 act at multiple stages of papillomavirus-induced disease at least in part via immunomodulatory mechanisms.

12 December 2023 in The Laryngoscope
Verified
Journal Article
Open access
RKRenee King
Renee King
JRJosef Rademacher
Josef Rademacher
EWElla T. Ward‐Shaw
Ella T. Ward‐Shaw
RHRong Hu
Rong Hu
ABAndrea Bilger
Andrea Bilger
PLPaul Lambert
Paul Lambert
ObjectiveMouse papillomavirus MmuPV1 causes both primary and secondary infections of the larynx in immunocompromised mice. Understanding lateral and vertical transmission of papillomavirus to the larynx would benefit patients with recurrent respiratory papillomatosis (RRP). To test the hypothesis that the larynx is uniquely vulnerable to papillomavirus infection, and to further develop a mouse model of RRP, we assessed whether immunocompetent mice were vulnerable to secondary or vertical laryngeal infection with MmuPV1.MethodsLarynges were collected from 405 immunocompetent adult mice that were infected with MmuPV1 in the oropharynx, oral cavity, or anus, and 31 mouse pups born to immunocompetent females infected in the cervicovaginal tract. Larynges were analyzed via polymerase chain reaction (PCR) of lavage fluid or whole tissues for viral DNA, histopathology, and/or in situ hybridization for MmuPV1 transcripts.ResultsDespite some positive laryngeal lavage PCR screens, all laryngeal tissue PCR and histopathology results were negative for MmuPV1 DNA, transcripts, and disease. There was no evidence for lateral spread of MmuPV1 to the larynges of immunocompetent mice that were infected in the oral cavity, oropharynx, or anus. Pups born to infected mothers were negative for laryngeal MmuPV1 infection from birth through weaning age.ConclusionSecondary and vertical laryngeal MmuPV1 infections were not found in immunocompetent mice. Further work is necessary to explore immunologic control of laryngeal papillomavirus infection in a mouse model and to improve preclinical models of RRP.Level of EvidenceN/a Laryngoscope, 2023 In humans, human papillomaviruses that cause recurrent respiratory papillomatosis can spread to the larynx from other tissue sites (secondary infection), and to the larynx of infants from genitally infected mothers (vertical infection). We examined larynges of over 430 immunocompetent adult and juvenile mice infected with mouse papillomavirus MmuPV1 in tissues other than the larynx or born to infected mothers, respectively, and found no evidence of secondary or vertical laryngeal MmuPV1 infection. These results have clinically important implications regarding laryngeal vulnerability to HPV infection.image

10 December 2025 in The Laryngoscope
Verified
Journal Article
Open access
RKRenee King
Renee King
EWElla T. Ward‐Shaw
Ella T. Ward‐Shaw
PLPaul Lambert
Paul Lambert
Objectives: Vocal fold (VF) injury and instillation are emerging techniques to study laryngeal pathologies in mouse models. Most approaches require high‐tech visualization and lengthy anesthesia. Intraperitoneal (IP) naphthalene (NAPH) and topical polidocanol (PDOC) are two chemical methods of injuring murine lower airways. Oropharyngeal aspiration (OA) is used for murine lung instillation. We assessed whether these simple low‐tech methods could injure and instill mouse VFs, and whether injury increased in vivo VF epithelial permeability. Methods: Mouse VFs were injured using IP NAPH at 200, 250, 300, or 350 mg/kg, or OA of PDOC at 0.5% or 2% w/v. Twenty‐four hours later, mice received Evans blue (EB) dye OA instillation, then were sacrificed after 30 min. Coronal larynx sections were assessed for VF injury. Permeability was measured by imaging EB autofluorescence and quantifying percent positive area and signal intensity. VFs were immunostained for basal cells (p63), tight junctions (ZO‐1), and basement membrane (laminin). Results: VF injury was 100% with 350 mg/kg NAPH or high‐volume 2% PDOC and 0%–40% with other treatments. EB bound VF lamina propria in up to 100% of mice in a volume‐dependent manner. Permeability did not differ by injury. Basal cells and tight junctions were decreased in injured VFs. Basement membrane was largely intact. Conclusions: High‐dose NAPH consistently injures mouse VFs. OA reliably instills mouse VFs. Uninjured murine VF epithelium is highly permeable to low molecular weight dye in vivo. Inherent permeability of mouse VFs may facilitate targeted genetic engineering approaches and studies of environmental hazards and drug treatments. Level of Evidence: n/a.